Hudson–Stahli line

From WikiMD's WELLNESSPEDIA

(Redirected from Hudson-Stahli line)

Hudson–Stahli line is a horizontal line that appears in the lower third of the cornea. It is named after the American ophthalmologists, Benjamin Hudson and Robert Stahli, who first described it in 1963. The line is composed of iron deposits and is most commonly seen in individuals over the age of 40.

Etymology[edit]

The Hudson–Stahli line is named after the American ophthalmologists, Benjamin Hudson and Robert Stahli, who first described it in 1963.

Description[edit]

The Hudson–Stahli line is a horizontal line that appears in the lower third of the cornea. It is composed of iron deposits and is most commonly seen in individuals over the age of 40. The line is usually 1-2mm in height and can extend across the entire width of the cornea. It is more commonly observed in the lower half of the cornea, but can occasionally be seen in the upper half as well.

Clinical significance[edit]

The presence of a Hudson–Stahli line is generally considered to be a normal age-related change and is not associated with any disease or disorder. However, it can sometimes be mistaken for other conditions that also result in iron deposition in the cornea, such as Fleischer ring or Ferry's line. Therefore, it is important for healthcare professionals to be aware of this condition and to differentiate it from other similar conditions.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.